The protein Ocular albinism 1 is the orphan GPCR GPR143 and mediates depressor and bradycardic responses to DOPA in the nucleus tractus solitarii

British Journal of Pharmacology

Volumn 171, Issue 2, 2014, Pages 403-414

  Hiroshima, Y ^a   Miyamoto, H ^a   Nakamura, F ^a   Masukawa, D ^a   Yamamoto, T ^a   Muraoka, H ^a   Kamiya, M ^a   Yamashita, N ^a   Suzuki, T ^b   Matsuzaki, S ^c   Endo, I ^a   Goshima, Y ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOSHI UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

4 dihydroxyphenylalanine; baroreceptor reflex; G protein coupled receptor; L 3; neurotransmitter; nucleus tractus solitarii

Indexed keywords

ADENOVIRUS VECTOR; ANTIBODY; CALCIUM ION; DOPA; DOPA CYCLOHEXYLESTER; DOPAMINE; GLUTAMIC ACID; HYDROGEN DOPA H 3; HYDROXYAMINO ACID; MYC PROTEIN; OCULAR ALBINISM 1; OCULAR ALBINISM 1 ANTIBODY; PEPTIDES AND PROTEINS; PHENYLEPHRINE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BRADYCARDIA; COMPETITIVE INHIBITION; CONTROLLED STUDY; DEPRESSOR RESPONSE; DRUG RECEPTOR BINDING; GENE SILENCING; HYPOTHALAMUS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SOLITARY TRACT NUCLEUS;

4-DIHYDROXYPHENYLALANINE; BARORECEPTOR REFLEX; G-PROTEIN COUPLED RECEPTOR; L-3; NEUROTRANSMITTER; NUCLEUS TRACTUS SOLITARII;

ANIMALS; BLOTTING, WESTERN; BRADYCARDIA; CERCOPITHECUS AETHIOPS; CHO CELLS; COS CELLS; CRICETINAE; CRICETULUS; DEPENDOVIRUS; DIHYDROXYPHENYLALANINE; DOPAMINE AGENTS; GENE TRANSFER TECHNIQUES; HEART RATE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; PLASMIDS; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, G-PROTEIN-COUPLED; SOLITARY NUCLEUS;

EID: 84891277585     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12459     Document Type: Article

References (33)

1. Aicher SA, Milner TA, Pickel VM, Reis DJ, (2000). Anatomical substrates for baroreflex sympathoinhibition in the rat. Brain Res Bull 51: 107-110. (Pubitemid 30069871)
2. Alexander SPH, et al. (2013). The Concise Guide to PHARMACOLOGY 2013/14: Overview. Br J Pharmacol 170: 1449-1867.
3. Andresen MC, Mendelowitz D, (1996). Sensory afferent neurotransmission in caudal nucleus tractus solitarius-common denominators. Chem Senses 21: 387-395. (Pubitemid 26183872)
4. Aoki R, Yagami T, Sasakura H, Ogura K, Kajihara Y, Ibi M, et al. (2011). A seven-transmembrane receptor that mediates avoidance response to dihydrocaffeic acid, a water-soluble repellent in Caenorhabditis elegans. J Neurosci 31: 16603-16610.
5. Bartholini G, Burkard WP, Pletscher A, (1967). Increase of cerebral catecholamines caused by 3,4-dihydroxyphenylalanine after inhibition of peripheral decarboxylase. Nature 215: 852-853.
6. Calne DB, Brennan J, Spiers AS, Stern GM, (1970). Hypotension caused by L-DOPA. Br Med J 1: 474-475.
7. Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM, (1996). ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 62: 155-169. (Pubitemid 26140102)
8. Furukawa N, Goshima Y, Miyamae T, Sugiyama Y, Shimizu M, Ohshima E, et al. (2000). L-DOPA cyclohexyl ester is a novel potent and relatively stable competitive antagonist against L-DOPA among several L-DOPA ester compounds. Jpn J Pharmacol 82: 40-47. (Pubitemid 30098649)
9. Garner A, Jay BS, (1980). Macromelanosomes in X-linked ocular albinism. Histopathology 4: 243-254. (Pubitemid 10062980)
10. Goshima Y, Kubo T, Misu Y, (1986). Biphasic actions of L-DOPA on the release of endogenous noradrenaline and dopamine in rat hypothalamic slices. Br J Pharmacol 89: 229-234. (Pubitemid 16031223)
11. Goshima Y, Kubo T, Misu Y, (1988). Transmitter-like release of endogenous 3,4-dihydroxyphenylalanine from rat striatal slices. J Neurochem 50: 1725-1730.
12. Goshima Y, Nakamura S, Misu Y, (1991). L-dihydroxyphenylalanine methyl-ester is a potent competitive antagonist of the L-dihydroxyphenylalanine- induced facilitation of the evoked release of endogenous norepinephrine from rat hypothalamic slices. J Pharmacol Exp Ther 258: 466-471.
13. Hoehn MM, (1975). Levodopa-induced postural hypotension. Treatment with fludrocortisone. Arch Neurol 32: 50-51.
14. Iravani MM, Jenner P, (2011). Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation. J Neural Transm 118: 1661-1690.
15. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: Reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
16. Kubo T, Yue JL, Goshima Y, Nakamura S, Misu Y, (1992). Evidence for L-DOPA systems responsible for cardiovascular control in the nucleus tractus solitarii of the rat. Neurosci Lett 140: 153-156.
17. Lopez VM, Decatur CL, Stamer WD, Lynch RM, McKay BS, (2008). L-DOPA is an endogenous ligand for OA1. Plos Biol 6: e236-e236.
18. McGrath J, Drummond G, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
19. Mathias CJ, (2002). Neurodegeneration, Parkinsonian syndromes and autonomic failure. Auton Neurosci 96: 50-58. (Pubitemid 34158555)
20. Milligan G, (2009). G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function. Br J Pharmacol 158: 5-14.
21. Misu Y, Goshima Y, (1993). Is L-DOPA an endogenous neurotransmitter. Trends Pharmacol Sci 14: 119-123.
22. Misu Y, Kitahama K, Goshima Y, (2003). L-3,4-dihydroxyphenylalanine as a neurotransmitter candidate in the central nervous system. Pharmacol Ther 97: 117-137. (Pubitemid 36138819)
23. Miyamae T, Goshima Y, Shimizu M, Shibata T, Kawashima K, Ohshima E, et al. (1999). Some interactions of L-DOPA and its related compounds with glutamate receptors. Life Sci 64: 1045-1054. (Pubitemid 29130563)
24. O'Donnell FE Jr, Hambrick GW Jr, Green WR, Iliff WJ, Stone DL, (1976). X-linked ocular albinism. An oculocutaneous macromelanosomal disorder. Arch Ophthalmol 94: 1883-1892. (Pubitemid 8258100)
25. Ohta H, Talman WT, (1994). Both NMDA and non-NMDA receptors in the NTS participate in the baroreceptor reflex in rats. Am J Physiol 267: R1065-R1070.
26. Okamura H, Kitahama K, Mons N, Ibata Y, Jouvet M, Geffard M, (1988). L-DOPA-immunoreactive neurons in the rat hypothalamic tuberal region. Neurosci Lett 95: 42-46.
27. Schiaffino MV, d'Addio M, Alloni A, Baschirotto C, Valetti C, Cortese K, et al. (1999). Ocular albinism: evidence for a defect in an intracellular signal transduction system. Nat Genet 23: 108-112. (Pubitemid 29418799)
28. Sugaya Y, Sasaki Y, Goshima Y, Kitahama K, Kusakabe T, Miyamae T, et al. (2001). Autoradiographic studies using L-[(14)C]DOPA and L-DOPA reveal regional Na(+)-dependent uptake of the neurotransmitter candidate L-DOPA in the CNS. Neuroscience 104: 1-14. (Pubitemid 32322608)
29. Sun MK, (1996). Pharmacology of reticulospinal vasomotor neurons in cardiovascular regulation. Pharmacol Rev 48: 465-494.
30. Surace EM, Angeletti B, Ballabio A, Marigo V, (2000). Expression pattern of the ocular albinism type 1 (Oa1) gene in the murine retinal pigment epithelium. Invest Ophthalmol Vis Sci 41: 4333-4337.
31. Talman WT, Perrone MH, Reis DJ, (1980). Evidence for L-glutamate as the neurotransmitter of baroreceptor afferent nerve-fibers. Science 209: 813-815. (Pubitemid 10017490)
32. Watanabe AM, Chase TN, Cardon PV, (1970). Effect of L-DOPA alone and in combination with an extracerebral decarboxylase inhibitor on blood pressure and some cardiovascular reflexes. Clin Pharmacol Ther 11: 740-746.
33. Yue JL, Okamura H, Goshima Y, Nakamura S, Geffard M, Misu Y, (1994). Baroreceptor-aortic nerve-mediated release of endogenous L-3,4- dihydroxyphenylalanine and its tonic depressor function in the nucleus tractus solitarii of rats. Neuroscience 62: 145-161.